Cutaneous manifestations of inflammatory bowel disease

Tunisie Medicale

Volumn 88, Issue 6, 2010, Pages 420-423

  Mnif, Leila ^a   Amouri, Ali ^a   Tahri, Nabil ^a  

^a HEDI CHAKER HOSPITAL   (Tunisia)

Author keywords

Crohn's disease; Granulomatous cutaneous lesions; Inflammatory bowel disease; Reactive skin eruptions; Ulcerative colitis

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; DAPSONE; INFLIXIMAB; LIDOCAINE; TACROLIMUS;

ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; APHTHOUS STOMATITIS; CROHN DISEASE; DISEASE ASSOCIATION; ERYTHEMA NODOSUM; FISTULA; GRANULOMATOUS SKIN DISEASE; HUMAN; MEDLINE; PYODERMA GANGRENOSUM; PYOSTOMATITIS VEGETANS; REACTIVE SKIN ERUPTION; REVIEW; SKIN DISEASE; SKIN ULCER; STOMATITIS; ULCERATIVE COLITIS;

HUMANS; INFLAMMATORY BOWEL DISEASES; SKIN DISEASES;

EID: 77954721635     PISSN: 00414131     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Tavarela Veloso F. Review article: skin complications associated with inflammatory bowel disease. Aliment Pharmacol Ther 2004; 20: 50-3.
2. Tavarela Veloso F, Carvalho S, Magro F. Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients. J Clin Gastroenterol 1996; 23: 29-34. (Pubitemid 26244497)
3. Rankin GB, Watts HD, Melnyk CS, et al. National Cooperative Crohn's Disease Study: extraintestinal manifestations and perianal complications. Gastroenterology 1979; 77: 914-20.
4. Jones J, Tremaine W. Evaluation of perianal fistulas in patients with crohn's disease. MedGenMed 2005; 7: 16.
5. Sandborn WJ, Fazio VW, Feagan BG, et al. AGA technical review on perianal crohn's disease. Gastroenterology 2003; 125: 150-30.
6. Asquith P, Thompson RA, Cooke WT. Oral manifestations of crohn's disease. Gut 1975; 16: 249-54.
7. Moravvej H, Razavi GM, Farshchian M, et al. Cutaneous manifestations in 404 Iranian patients with inflammatory bowel disease: A retrospective study. Indian J Dermatol Venereol Leprol 2008; 74: 607-10.
8. Shller KFR, Golding P-L, Peebles RA, et al. Crohn's disease of the mouth and lips. Gut 1971; 12: 864.
9. MacPhail L. Topical and systemic therapy for recurrent aphthous stomatitis. Seminars Cutaneous Medicine and Surgery 1997; 16: 301-7. (Pubitemid 28009579)
10. Cardoso H, Nunes AC, Carneiro F, et al. Successful Infliximab therapy for oral crohn's disease. Inflamm Bowel Dis 2006; 12: 337-8.
11. Calobrisi S, Mutasim D, McDonald J. Pyostomatitis vegetans associated with ulcerative colitis: temporary clearance with fluocinonide gel and complete remission after colectomy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995; 79: 452-4.
12. Storwick G, Prihoda M, Fulton R, et al. Pyodermatitis - pyostomatitis vegetans: a specific marker for inflammatory bowel disease. J Am Acad Dermatol 1994; 31: 336-41. (Pubitemid 24249261)
13. Brinkmeier T, Frosch PJ. Pyodermatitis - pyostomatitis vegetans: A clinical course of two decades with response to cyclosporine and low - dose prednisolone. Acta Derm Venereol 2001; 81: 134-6. (Pubitemid 32662156)
14. Berkowitz EZ, Lebwohl M. Cutaneous manifestations of inflammatory bowel disease. JEADV 2000; 14: 349-50.
15. Lebwohl M, Lebwohl O. Cutaneous manifestations of inflammatory bowel disease. Inflamm Bowel Dis 1998; 4: 142-8. (Pubitemid 128699845)
16. Kafity AA, Pellegrini AE, Fronkes JJ. Metastatic crohn's disease.A rare cutaneous manifestation. J Clin Gastroenterol 1993; 17: 300-3.
17. Van Dullemen H, De Jong E, Slors F, et al. Treatment of therapy - resistant perianal metastatic crohn's disease after protectomy using anti-tumor necrosis factor chimeric monoclonal antibody, cA2: report of two cases. Dis Colon Rectum 1998; 41: 98-102. (Pubitemid 28044883)
18. Apgar JT. Newer aspects of inflammatory bowel disease and its cutaneous manifestations: a selective review. Semin Dermatol 1991; 10: 138-47.
19. Trost LB, McDonnell JK. Important cutaneous manifestations of inflammatory bowel disease. Postgrad Med J 2005; 81: 580-5.
20. Fleisher M, Rubin S, Levine A, et al. Infliximab in the treatment of steroid refractory erythema nodosum of IBD. Gastroenterology 2002; 122 (Suppl. 1): A 618 (Abstract).
21. Brooklyn T, Dunnill G, Probert C. Diagnosis and treatment of pyoderma gangrenosum. BMJ 2006; 333: 181-4.
22. Brooklyn T, Dunnill GS, Shetty A, et al. Infliximab for the treatment of pyoderma gangrenosum: a randomized, double - blind placebo - controlled trial. Gut 2006; 55: 505-9.
23. Ardizzone S, Sarzi Puttini P, Cassinotti A, et al. Extraintestinal manifestations of inflammatory bowel disease. Dig Liver Dis 2008; 40 (Suppl. 2): S 253-9.
24. Cohen AD, Dreiher J, Birkenfeld S. Psoriasis associated with ulcerative colitis and crohn's disease. J Eur Acad Dermatol Venereol 2009; 23 : 561-5.
25. Lee FI, Bellary SV, Francis C. Increased occurrence of psoriasis in patients with crohn's disease and their relatives. Am J Gastroenterol 1990; 85: 962-3. (Pubitemid 20235791)